# Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults

> **NCT03531242** · PHASE2 · NOT_YET_RECRUITING · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 500 (estimated)

## Conditions studied

- Venezuelan Equine Encephalomyelitis

## Interventions

- **BIOLOGICAL:** 0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1

## Key facts

- **NCT ID:** NCT03531242
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-06
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03531242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03531242, "Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT03531242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*